EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.21.B39 | medicine | regulation by protease inhibitors may have potential clinical applications | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.4.21.B39 | DNA sequence determination and analysis, expression in CHO-CCL-61 cells, in Escherichia coli, and in Pichia pastoris | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.B39 | alpha1-antitrypsin | - |
Homo sapiens | |
3.4.21.B39 | alpha2-Macroglobulin | - |
Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.4.21.B39 | 28000 | - |
recombinant deglycosylated enzyme, gel filtration | Homo sapiens |
3.4.21.B39 | 30000 | - |
recombinant glycosylated protein, gel filtration | Homo sapiens |
3.4.21.B39 | 40000 | - |
native glycosylated enzyme, gel filtration | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.B39 | additional information | Homo sapiens | the enzyme is differentially expressed at the mRNA and protein level in diverse malignancies including cancer | ? | - |
? | |
3.4.21.B39 | polypeptide + H2O | Homo sapiens | enzyme is regulated by binding to protease inhibitors | peptides | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.B39 | Homo sapiens | Q9Y337 | gene KLK5 | - |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
3.4.21.B39 | glycoprotein | N-glycosylated | Homo sapiens |
3.4.21.B39 | glycoprotein | 4 potential N-glycosylation sites at amino acid residues positions 69, 173, 208, and 252 | Homo sapiens |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.21.B39 | recombinant enzyme from CHO-CCL-61 cells and from Pichia pastoris | Homo sapiens |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
3.4.21.B39 | proteolytic cleavage of polypeptides | enzyme is a serine protease | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.21.B39 | ascites fluid | from ovarian cancer patients | Homo sapiens | - |
3.4.21.B39 | milk | - |
Homo sapiens | - |
3.4.21.B39 | serum | female and male | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.B39 | FSR-amido-4-methylcoumarin + H2O | fluorogenic trypsin-like peptide substrate | Homo sapiens | FSR + 7-amino-4-methylcoumarin | - |
? | |
3.4.21.B39 | additional information | no activity with AAPF-amido-4-methylcoumarin | Homo sapiens | ? | - |
? | |
3.4.21.B39 | additional information | enzyme shows trypsin-like but not chymotrypsin-like activity | Homo sapiens | ? | - |
? | |
3.4.21.B39 | additional information | the enzyme is differentially expressed at the mRNA and protein level in diverse malignancies including cancer | Homo sapiens | ? | - |
? | |
3.4.21.B39 | polypeptide + H2O | - |
Homo sapiens | peptides | - |
? | |
3.4.21.B39 | polypeptide + H2O | enzyme is regulated by binding to protease inhibitors | Homo sapiens | peptides | - |
? | |
3.4.21.B39 | VPR-amido-4-methylcoumarin + H2O | fluorogenic trypsin-like peptide substrate | Homo sapiens | VPR + 7-amino-4-methylcoumarin | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.21.B39 | K5 | - |
Homo sapiens |
3.4.21.B39 | kallikrein protein 5 | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.4.21.B39 | 37 | - |
- |
Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.4.21.B39 | 8 | - |
assay at | Homo sapiens |